Infantile apnoea is a breathing condition where babies experience pauses in breathing lasting more than 15 to 20 seconds, often accompanied by changes in heart rate or skin colour. Understanding when and how this condition is diagnosed can help parents feel more prepared and less anxious during what is often a worrying time for families.

Introduction: Who Should Undergo Diagnostics

Parents should seek medical attention if they notice their infant stopping breathing for extended periods, turning blue or pale, having a slow heart rate, or appearing limp during these episodes. These warning signs require immediate evaluation, even if the baby seems to recover on their own.^[1] While brief pauses in breathing are normal in newborns—a pattern called periodic breathing that involves short pauses of 5 to 10 seconds—true apnoea involves longer pauses or shorter pauses accompanied by worrying symptoms.^[2]

Premature babies are at highest risk for infantile apnoea and should undergo diagnostic monitoring as a standard part of their care. The earlier a baby is born, the more likely they are to experience these breathing problems. Babies born before 28 weeks have the highest risk, with more than 60 percent experiencing apnoea, while babies born between 34 and 35 weeks have about a 10 percent chance.^[7] However, full-term babies can also develop apnoea, and when they do, doctors investigate more thoroughly because it may signal an underlying medical problem rather than simple immaturity.

Healthcare providers also recommend diagnostic evaluation for babies who have had what doctors call a brief resolved unexplained event, previously known as an apparent life-threatening event. This happens when parents or caregivers witness a frightening episode where the baby stops breathing, changes colour, becomes limp, or appears to choke or gag.^[4] Even if the baby recovers quickly, these episodes warrant medical investigation to rule out serious conditions and determine whether the infant needs ongoing monitoring or treatment.

Babies with certain medical conditions face higher risk and may need diagnostic testing even without obvious symptoms. These include infants born with low birth weight, those with heart problems, babies exposed to certain medications before birth, infants with infections, and those with conditions affecting the brain or nervous system.^[1] Babies with physical differences such as Down syndrome, small jaw structures, or other craniofacial conditions also face increased risk because these features can narrow the airway and make breathing more difficult during sleep.^[3]

Diagnostic Methods

The primary diagnostic tool for infantile apnoea is continuous monitoring in a hospital setting, particularly in the neonatal intensive care unit. When babies are admitted to the NICU, healthcare providers attach sensors to monitor their breathing patterns, heart rate, and oxygen levels continuously.^[9] These monitors sound an alarm when breathing stops for a dangerous length of time or when the heart rate drops too low. This allows medical staff to intervene quickly and also provides valuable information about how often and how severely the baby experiences these episodes.

The most comprehensive diagnostic test for sleep apnoea in infants is called a polysomnogram, which is an overnight sleep study conducted in a specialized sleep laboratory. During this test, technicians place multiple sensors on the baby’s body to record brain waves, breathing patterns, oxygen saturation, heart rate, and muscle activity throughout the night.^[8] This detailed recording helps doctors understand exactly what happens during sleep, distinguish between different types of apnoea, and identify patterns that might otherwise go unnoticed. The test must be performed in a pediatric sleep center where staff have expertise working with infants, as interpreting sleep studies in babies differs significantly from interpreting them in adults.^[13]

Doctors classify infantile apnoea into three main types based on what the diagnostic tests reveal. Central apnoea occurs when the brain fails to send proper signals to the breathing muscles, so both the breathing effort and airflow stop at the same time. This type accounts for about 40 percent of cases and shows up on monitoring as an absence of both chest wall movement and airflow.^[7] Obstructive apnoea happens when something blocks the airway, preventing air from reaching the lungs even though the baby tries to breathe. On monitoring, this appears as chest movement without any airflow, accounting for about 10 percent of cases. Mixed apnoea, which combines features of both types, is the most common form in premature infants, representing about 50 percent of cases.^[3]

Physical examination forms an essential part of the diagnostic process. Healthcare providers carefully examine the baby’s head, neck, nose, mouth, and tongue to look for any structural problems that might block the airway or contribute to breathing difficulties.^[4] They check the position of the baby’s jaw, look for enlarged tonsils or adenoids, and assess whether the airway passages are appropriately sized and shaped. Sometimes physical features that seem minor can significantly affect breathing during sleep.

Blood tests help doctors determine whether underlying conditions are causing the apnoea. Laboratory tests can check for infection, measure blood cell counts, evaluate electrolyte levels such as calcium and sodium, and assess blood sugar levels.^[6] Low blood sugar, abnormal calcium levels, or infections can all trigger apnoea episodes in infants. Blood tests also measure oxygen levels to see how well the baby’s body is getting the oxygen it needs. Some babies may have additional blood work to check for anemia, which means the blood doesn’t carry enough oxygen and can contribute to breathing problems.

Imaging studies provide another layer of diagnostic information. X-rays of the chest help doctors look for lung problems, pneumonia, or structural abnormalities that might interfere with breathing.^[9] If doctors suspect problems with the brain or nervous system, they may order brain imaging such as ultrasound or other scans to look for bleeding, tissue damage, or developmental issues that could affect the breathing control center in the brain. These imaging tests are particularly important for premature babies who face higher risks of brain complications.

Pulse oximetry is a simple, non-invasive test that measures oxygen levels in the blood. A small sensor, usually placed on the baby’s foot or hand, uses light to measure how much oxygen the blood is carrying.^[14] This test runs continuously in the NICU and provides immediate feedback about whether apnoea episodes are causing dangerous drops in oxygen levels. The test is painless and doesn’t interfere with the baby’s care or comfort.

Doctors must also investigate other possible causes that might explain the breathing problems. They evaluate for heart conditions by listening to heart sounds and sometimes performing an electrocardiogram, which records the electrical activity of the heart. They check for gastroesophageal reflux, a condition where stomach contents come back up into the oesophagus, because this can trigger apnoea episodes.^[1] Healthcare providers also review the mother’s medical history and any medications or substances she was exposed to during pregnancy, as certain drugs can affect the baby’s breathing control after birth.

Neurological assessment becomes important when doctors suspect that apnoea might be related to seizures or other brain activity problems. An electroencephalogram, known as an EEG, records the brain’s electrical activity and can detect seizures that might not be obvious from just watching the baby.^[7] While apnoea as a seizure symptom is uncommon in newborns, it needs to be ruled out, especially if the baby has other risk factors such as birth complications or family history of neurological conditions.

Diagnostics for Clinical Trial Qualification

When infants with apnoea are being considered for enrollment in clinical trials testing new treatments or interventions, they undergo standardized diagnostic procedures to ensure they meet specific criteria. These qualification assessments are more rigorous than routine diagnostic evaluation and follow protocols that allow researchers to compare results across different study sites and participants.

The gestational age at birth serves as a primary qualification criterion for most apnoea clinical trials. Researchers typically define apnoea of prematurity specifically as occurring in infants born before 37 weeks of gestation, so accurate dating of the pregnancy becomes crucial for trial enrollment.^[1] Medical records documenting prenatal ultrasounds and other pregnancy dating methods help establish eligibility. Some trials focus exclusively on extremely premature infants born before 28 weeks, while others include a broader range of gestational ages, so precise documentation of birth timing is essential.

Standardized monitoring protocols document the frequency and severity of apnoea episodes according to specific definitions used in research settings. Most clinical trials require that apnoea be defined as a breathing pause lasting at least 20 seconds or a shorter pause accompanied by bradycardia (heart rate below 80 beats per minute) or oxygen desaturation.^[4] Monitors record these parameters continuously over specified periods, typically several days, to establish baseline measurements before any intervention begins. This baseline data allows researchers to measure whether experimental treatments reduce the frequency or severity of episodes.

Blood oxygen saturation monitoring follows strict protocols in clinical trials. Researchers specify exact thresholds for what constitutes clinically significant oxygen desaturation, often defined as oxygen saturation dropping below 85 or 90 percent for a specified duration.^[16] These measurements must be taken using calibrated equipment, and readings are often reviewed by independent assessors to ensure consistency across study sites. The duration and recovery time from desaturation events also get recorded as important outcome measures.

Clinical trials investigating apnoea treatments typically require polysomnography at specified time points to provide objective, comprehensive assessment of breathing patterns during sleep. Unlike routine clinical care where a single sleep study might suffice for diagnosis, research protocols often require multiple sleep studies: one at enrollment, additional studies during treatment, and follow-up studies to assess long-term outcomes.^[8] These studies must be conducted using standardized procedures and interpreted by qualified sleep medicine specialists who are often blinded to which treatment the infant is receiving to prevent bias in the interpretation.

Exclusion criteria in clinical trials require thorough diagnostic workup to rule out other conditions that might mimic or complicate apnoea of prematurity. Researchers typically exclude infants with major congenital abnormalities, severe intraventricular hemorrhage, active infections, or other serious medical conditions that could confound the study results or put the infant at additional risk.^[6] This means infants undergo comprehensive physical examination, laboratory testing including complete blood counts and cultures if infection is suspected, and often brain imaging to document the absence of significant bleeding or structural problems.

Cardiovascular assessment becomes part of trial qualification procedures because heart function can both influence and be influenced by apnoea. Many research protocols require echocardiography to evaluate heart structure and function, assess for patent ductus arteriosus (a blood vessel that doesn’t close properly after birth), and ensure the infant’s cardiovascular system can tolerate the interventions being studied.^[7] Electrocardiogram monitoring provides baseline heart rhythm data and helps identify any underlying cardiac abnormalities that might exclude an infant from participation.

Neurological evaluation for trial enrollment often exceeds what’s done in routine care. Researchers may require cranial ultrasound or other brain imaging to classify the severity of any brain hemorrhage or injury and establish neurological status at enrollment. Some trials tracking long-term developmental outcomes conduct baseline neurological examinations and developmental assessments so researchers can later determine whether treatments affect not just immediate breathing outcomes but also longer-term brain development and function.^[3]

Laboratory assessments for clinical trial qualification typically include comprehensive metabolic panels to measure electrolytes, glucose, calcium, and other blood chemistry values that might affect breathing control. Researchers want to ensure that metabolic derangements aren’t causing or contributing to the apnoea, as this could affect whether the trial intervention appears effective.^[7] Some trials also measure blood gas levels to assess how well the infant is exchanging oxygen and carbon dioxide, providing another objective measure of respiratory function.

Documentation requirements for clinical trials are extensive. All diagnostic tests must be performed according to standardized protocols with results recorded in specified formats that allow for consistent analysis across study sites. This often means repeating tests even if they were performed recently as part of clinical care, because research protocols require tests done with specific equipment, timing, or methodology. The data from these diagnostic tests form the evidence base that regulatory agencies use to evaluate whether new treatments are safe and effective.